Login    Join free Add to favorites    中文
Home >Products> Reagents >Other Reagents> Nimacimab
Nimacimab
Nimacimab
Origin of place Singapore
Model UA011050-100μg
Supplier ANT BIO PTE.LTD.
Price 252
Hits 5
Updated 8/27/2025
  • Product Detail
  • Company Profile

Product Specification


SynonymsNamacizumab, Nimacimab (USAN), JNJ-2463, RYI-018
Concentration>95% by SDS-PAGE & SEC-HPLC
Expression SystemCHO
Molecular Weight

25-30kDa&45-55kDa (Reducing)

Endotoxin<1EU/μg
ConjugationUnconjugated
Physical AppearanceLyophilized Powder
Storage BufferPBS, PH7.4, 5% trehalose,5% mannitol
Reconstitution

Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.

Stability & Storage· 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
· 3 months, -20 to -80℃ under sterile conditions after reconstitution.
· 1 week, 2 to 8℃ under sterile conditions after reconstitution.
· Please avoid repeated freeze-thaw cycles.
Reference

1. Resat Cinar,et al.The therapeutic potential of second and third generation CB1R antagonists,Pharmacology & Therapeutics,Volume 208,2020,107477,ISSN 0163-7258.

Background

Nimacimab is a first of its kind humanized monoclonal antibody targeting the cannabinoid 1 receptor ("CB1")that acts as a negative allosteric modulator to inhibit peripheral CB1 signaling. Inhibition of CB1 has shown anti-fibrotic, anti-inflammatory, and metabolic mechanisms of action, and has the potential to address a wide range of diseases with significant unmet medical needs, such as obesity, chronic kidney disease, and non-alcoholic steatohepatitis (NASH).

bio-equip.cn
Request Infomation

* Name:
Title:
* Tel:
Fax:
* E-mail:
Postcode:
Institution/Company:
Address:
* Country:
Request infomation:
yes no
Request Quotation:
yes no
* Message:
Validated Code:
refresh
I agree to share my inquiry to the other matching suppliers.



Recently viewed products
Copyright(C) 2006-2025 Bio-Equip    E-mail:web@bio-equip.cn   沪ICP备06040519号